BPTES treatment alone did not induce cell death in TSC1/2 deficiency, although BPTES treatment increased the ROS levels.18 Here we found that BPTES treatment alone showed on average <20% increase of ROS levels in NSCLC under normal growth conditions (Figure 2a). The gene discussed is TSC1; the disease is non-small cell lung carcinoma.